Literature DB >> 25168830

Permeability factors in focal and segmental glomerulosclerosis.

Jochen Reiser1, Cynthia C Nast2, Nada Alachkar2.   

Abstract

Focal and segmental glomerulosclerosis (FSGS) represents a group of glomerular disorders, identified on kidney biopsy, that progress in the histopathologic pattern of sclerosis in parts of some glomeruli. Damage to podocytes usually marks the beginning of the disease, most evident in primary FSGS. In addition to genetic predisposition, there are many acquired causes that disturb normal podocyte homeostasis and allow for the development of FSGS. The aim of this review was to summarize recent findings of the most relevant circulating permeability factors that may serve as biomarkers of active primary idiopathic FSGS and aid in the diagnosis and prediction of recurrent FSGS after kidney transplantation.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Permeability factor; Recurrent focal and segmental glomerulosclerosis; Soluble urokinase receptor; suPAR

Mesh:

Substances:

Year:  2014        PMID: 25168830      PMCID: PMC4149759          DOI: 10.1053/j.ackd.2014.05.010

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  34 in total

Review 1.  uPAR: a versatile signalling orchestrator.

Authors:  Francesco Blasi; Peter Carmeliet
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

2.  The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.

Authors:  C F Sier; R Stephens; J Bizik; A Mariani; M Bassan; N Pedersen; L Frigerio; A Ferrari; K Danø; N Brünner; F Blasi
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

3.  Recurrence of focal segmental sclerosis in children following renal transplantation.

Authors:  J E Striegel; R K Sibley; D S Fryd; S M Mauer
Journal:  Kidney Int Suppl       Date:  1986-07       Impact factor: 10.545

4.  Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997.

Authors:  M Haas; S M Meehan; T G Karrison; B H Spargo
Journal:  Am J Kidney Dis       Date:  1997-11       Impact factor: 8.860

5.  Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.

Authors:  R Dall'Amico; G Ghiggeri; M Carraro; M Artero; L Ghio; E Zamorani; C Zennaro; G Basile; G Montini; L Rivabella; M Cardillo; M Scalamogna; F Ginevri
Journal:  Am J Kidney Dis       Date:  1999-12       Impact factor: 8.860

6.  Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.

Authors:  Chagriya Kitiyakara; Paul Eggers; Jeffrey B Kopp
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

7.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

Authors:  V J Savin; R Sharma; M Sharma; E T McCarthy; S K Swan; E Ellis; H Lovell; B Warady; S Gunwar; A M Chonko; M Artero; F Vincenti
Journal:  N Engl J Med       Date:  1996-04-04       Impact factor: 91.245

8.  Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study.

Authors:  A Tejani; D H Stablein
Journal:  J Am Soc Nephrol       Date:  1992-06       Impact factor: 10.121

9.  Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection.

Authors:  E M Kim; J Striegel; Y Kim; A J Matas; J S Najarian; S M Mauer
Journal:  Kidney Int       Date:  1994-05       Impact factor: 10.612

Review 10.  De novo glomerular diseases after renal transplantation.

Authors:  Claudio Ponticelli; Gabriella Moroni; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 8.237

View more
  17 in total

Review 1.  Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes.

Authors:  Cynthia C Nast; Kevin V Lemley; Jeffrey B Hodgin; Serena Bagnasco; Carmen Avila-Casado; Stephen M Hewitt; Laura Barisoni
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

2.  Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.

Authors:  Mukut Sharma; Jianping Zhou; Jean-François Gauchat; Ram Sharma; Ellen T McCarthy; Tarak Srivastava; Virginia J Savin
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

3.  Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.

Authors:  Pankaj Srivastava; Ashish K Solanki; Ehtesham Arif; Bethany J Wolf; Michael G Janech; Milos N Budisavljevic; Sang-Ho Kwon; Deepak Nihalani
Journal:  Kidney Int       Date:  2019-01-29       Impact factor: 10.612

4.  DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.

Authors:  Howard Trachtman; Peter Nelson; Sharon Adler; Kirk N Campbell; Abanti Chaudhuri; Vimal Kumar Derebail; Giovanni Gambaro; Loreto Gesualdo; Debbie S Gipson; Jonathan Hogan; Kenneth Lieberman; Brad Marder; Kevin Edward Meyers; Esmat Mustafa; Jai Radhakrishnan; Tarak Srivastava; Miganush Stepanians; Vladimír Tesar; Olga Zhdanova; Radko Komers
Journal:  J Am Soc Nephrol       Date:  2018-11       Impact factor: 10.121

Review 5.  The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease.

Authors:  Rupesh Raina; Abigail Chauvin; Ronith Chakraborty; Nikhil Nair; Haikoo Shah; Vinod Krishnappa; Kirsten Kusumi
Journal:  Kidney Dis (Basel)       Date:  2019-12-18

6.  Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

Authors:  Jian Liu; Jingyuan Xie; Xiaoyan Zhang; Jun Tong; Xu Hao; Hong Ren; Weiming Wang; Nan Chen
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

7.  Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).

Authors:  Radko Komers; Debbie S Gipson; Peter Nelson; Sharon Adler; Tarak Srivastava; Vimal K Derebail; Kevin E Meyers; Pablo Pergola; Meghan E MacNally; Jennifer L Hunt; Alvin Shih; Howard Trachtman
Journal:  Kidney Int Rep       Date:  2017-03-04

8.  Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.

Authors:  Mohammad Abuzeineh; Amtul Aala; Sami Alasfar; Nada Alachkar
Journal:  BMC Nephrol       Date:  2020-07-02       Impact factor: 2.388

Review 9.  Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Authors:  Andreas Kronbichler; Moin A Saleem; Björn Meijers; Jae Il Shin
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

10.  Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.

Authors:  Sophie Doublier; Cristina Zennaro; Luca Musante; Tiziana Spatola; Giovanni Candiano; Maurizio Bruschi; Luca Besso; Massimo Cedrino; Michele Carraro; Gian Marco Ghiggeri; Giovanni Camussi; Enrico Lupia
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.